Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
JBTM vs HLI vs EVR vs MIDD vs LAZ
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Industrial - Machinery
Financial - Capital Markets
JBTM vs HLI vs EVR vs MIDD vs LAZ — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Financial - Capital Markets | Financial - Capital Markets | Industrial - Machinery | Financial - Capital Markets |
| Market Cap | $7.18B | $10.71B | $13.11B | $7.38B | $4.36B |
| Revenue (TTM) | $3.88B | $2.39B | $3.88B | $3.73B | $3.19B |
| Net Income (TTM) | $168M | $448M | $592M | $-278M | $237M |
| Gross Margin | 35.3% | 38.5% | 99.4% | 37.9% | 31.8% |
| Operating Margin | 7.5% | 21.0% | 20.5% | -2.5% | 13.0% |
| Forward P/E | 16.8x | 19.9x | 17.5x | 17.0x | 14.5x |
| Total Debt | $1.88B | $438M | $1.16B | $2.17B | $2.58B |
| Cash & Equiv. | $187M | $971M | $1.47B | $222M | $1.50B |
JBTM vs HLI vs EVR vs MIDD vs LAZ — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| JBT Marel Corporati… (JBTM) | 100 | 167.9 | +67.9% |
| Houlihan Lokey, Inc. (HLI) | 100 | 253.7 | +153.7% |
| Evercore Inc. (EVR) | 100 | 600.7 | +500.7% |
| The Middleby Corpor… (MIDD) | 100 | 232.3 | +132.3% |
| Lazard Ltd (LAZ) | 100 | 172.9 | +72.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: JBTM vs HLI vs EVR vs MIDD vs LAZ
Each card shows where this stock fits in a portfolio — not just who wins on paper.
JBTM ranks third and is worth considering specifically for growth exposure.
- Rev growth 121.3%, EPS growth -137.4%, 3Y rev CAGR 33.7%
- 121.3% revenue growth vs MIDD's -17.4%
HLI carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 7 yrs, beta 0.94, yield 1.6%
- Lower volatility, beta 0.94, Low D/E 20.1%, current ratio 1.38x
- PEG 1.26 vs EVR's 1.55
- Better valuation composite
EVR is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 6.1% 10Y total return vs HLI's 6.0%
- +60.9% vs HLI's -5.1%
- 14.1% ROA vs MIDD's -4.1%, ROIC 18.8% vs 8.7%
MIDD lags the leaders in this set but could rank higher in a more targeted comparison.
LAZ is the clearest fit if your priority is defensive.
- Beta 1.79, yield 3.8%, current ratio 29.35x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 121.3% revenue growth vs MIDD's -17.4% | |
| Value | Better valuation composite | |
| Quality / Margins | 16.7% margin vs MIDD's -7.4% | |
| Stability / Safety | Beta 0.94 vs EVR's 1.90, lower leverage | |
| Dividends | 1.6% yield, 7-year raise streak, vs LAZ's 3.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +60.9% vs HLI's -5.1% | |
| Efficiency (ROA) | 14.1% ROA vs MIDD's -4.1%, ROIC 18.8% vs 8.7% |
JBTM vs HLI vs EVR vs MIDD vs LAZ — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
JBTM vs HLI vs EVR vs MIDD vs LAZ — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HLI leads in 2 of 6 categories
LAZ leads 1 • EVR leads 1 • JBTM leads 0 • MIDD leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
HLI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JBTM is the larger business by revenue, generating $3.9B annually — 1.6x HLI's $2.4B. HLI is the more profitable business, keeping 16.7% of every revenue dollar as net income compared to MIDD's -7.4%. On growth, JBTM holds the edge at +9.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.9B | $2.4B | $3.9B | $3.7B | $3.2B |
| EBITDAEarnings before interest/tax | $557M | $591M | $804M | $26M | $384M |
| Net IncomeAfter-tax profit | $168M | $448M | $592M | -$278M | $237M |
| Free Cash FlowCash after capex | $317M | $739M | $1.2B | $559M | $519M |
| Gross MarginGross profit ÷ Revenue | +35.3% | +38.5% | +99.4% | +37.9% | +31.8% |
| Operating MarginEBIT ÷ Revenue | +7.5% | +21.0% | +20.5% | -2.5% | +13.0% |
| Net MarginNet income ÷ Revenue | +4.3% | +16.7% | +15.3% | -7.4% | +7.4% |
| FCF MarginFCF ÷ Revenue | +8.2% | +33.9% | +30.5% | +15.0% | +15.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.6% | — | — | -14.5% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +125.7% | +22.3% | +44.2% | -64.3% | -43.8% |
Valuation Metrics
LAZ leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 21.4x trailing earnings, LAZ trades at a 19% valuation discount to HLI's 26.4x P/E. Adjusting for growth (PEG ratio), HLI offers better value at 1.67x vs EVR's 2.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7.2B | $10.7B | $13.1B | $7.4B | $4.4B |
| Enterprise ValueMkt cap + debt − cash | $8.9B | $10.2B | $12.8B | $9.3B | $5.4B |
| Trailing P/EPrice ÷ TTM EPS | -139.32x | 26.37x | 23.56x | -29.41x | 21.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 16.81x | 19.92x | 17.50x | 17.03x | 14.52x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.67x | 2.08x | — | — |
| EV / EBITDAEnterprise value multiple | 19.79x | 18.75x | 15.91x | 13.56x | 12.09x |
| Price / SalesMarket cap ÷ Revenue | 1.89x | 4.48x | 3.38x | 2.30x | 1.37x |
| Price / BookPrice ÷ Book value/share | 1.62x | 4.84x | 6.33x | 2.94x | 4.99x |
| Price / FCFMarket cap ÷ FCF | 30.15x | 13.24x | 11.09x | 13.21x | 8.63x |
Profitability & Efficiency
HLI leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
EVR delivers a 29.3% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $-9 for MIDD. HLI carries lower financial leverage with a 0.20x debt-to-equity ratio, signaling a more conservative balance sheet compared to LAZ's 2.61x. On the Piotroski fundamental quality scale (0–9), HLI scores 7/9 vs JBTM's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.8% | +20.1% | +29.3% | -8.5% | +26.7% |
| ROA (TTM)Return on assets | +2.0% | +11.9% | +14.1% | -4.1% | +5.2% |
| ROICReturn on invested capital | +3.7% | +15.5% | +18.8% | +8.7% | +9.5% |
| ROCEReturn on capital employed | +4.0% | +20.1% | +17.6% | +10.1% | +9.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 7 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.42x | 0.20x | 0.50x | 0.78x | 2.61x |
| Net DebtTotal debt minus cash | $1.7B | -$533M | -$311M | $2.0B | $1.1B |
| Cash & Equiv.Liquid assets | $187M | $971M | $1.5B | $222M | $1.5B |
| Total DebtShort + long-term debt | $1.9B | $438M | $1.2B | $2.2B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | 3.83x | — | 32.72x | -1.20x | 4.74x |
Total Returns (Dividends Reinvested)
EVR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HLI five years ago would be worth $24,153 today (with dividends reinvested), compared to $8,654 for MIDD. Over the past 12 months, EVR leads with a +60.9% total return vs HLI's -5.1%. The 3-year compound annual growth rate (CAGR) favors EVR at 46.8% vs MIDD's 2.8% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -8.3% | -12.6% | -5.5% | +4.9% | -5.6% |
| 1-Year ReturnPast 12 months | +30.2% | -5.1% | +60.9% | +20.2% | +17.8% |
| 3-Year ReturnCumulative with dividends | +32.3% | +85.7% | +216.3% | +8.6% | +80.2% |
| 5-Year ReturnCumulative with dividends | -3.5% | +141.5% | +136.2% | -13.5% | +20.6% |
| 10-Year ReturnCumulative with dividends | +156.3% | +603.4% | +613.3% | +46.1% | +100.4% |
| CAGR (3Y)Annualised 3-year return | +9.8% | +22.9% | +46.8% | +2.8% | +21.7% |
Risk & Volatility
Evenly matched — HLI and MIDD each lead in 1 of 2 comparable metrics.
Risk & Volatility
HLI is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than EVR's 1.90 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MIDD currently trades 93.4% from its 52-week high vs HLI's 72.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.30x | 0.94x | 1.90x | 1.22x | 1.79x |
| 52-Week HighHighest price in past year | $170.19 | $211.78 | $388.71 | $169.44 | $58.75 |
| 52-Week LowLowest price in past year | $105.27 | $134.41 | $206.63 | $110.82 | $38.67 |
| % of 52W HighCurrent price vs 52-week peak | +81.0% | +72.5% | +85.2% | +93.4% | +79.0% |
| RSI (14)Momentum oscillator 0–100 | 58.5 | 36.6 | 53.0 | 52.2 | 50.9 |
| Avg Volume (50D)Average daily shares traded | 547K | 606K | 622K | 571K | 1.5M |
Analyst Outlook
Evenly matched — HLI and LAZ each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: JBTM as "Buy", HLI as "Buy", EVR as "Buy", MIDD as "Buy", LAZ as "Buy". Consensus price targets imply 30.5% upside for JBTM (target: $180) vs 1.9% for LAZ (target: $47). For income investors, LAZ offers the higher dividend yield at 3.78% vs JBTM's 0.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $180.00 | $200.00 | $382.67 | $176.67 | $47.33 |
| # AnalystsCovering analysts | 2 | 15 | 21 | 20 | 29 |
| Dividend YieldAnnual dividend ÷ price | +0.3% | +1.6% | +1.0% | — | +3.8% |
| Dividend StreakConsecutive years of raises | 0 | 7 | 0 | 3 | 1 |
| Dividend / ShareAnnual DPS | $0.40 | $2.41 | $3.25 | — | $1.75 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.5% | +5.0% | +9.8% | +2.1% |
HLI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). LAZ leads in 1 (Valuation Metrics). 2 tied.
JBTM vs HLI vs EVR vs MIDD vs LAZ: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is JBTM or HLI or EVR or MIDD or LAZ a better buy right now?
For growth investors, JBT Marel Corporation (JBTM) is the stronger pick with 121.
3% revenue growth year-over-year, versus -17. 4% for The Middleby Corporation (MIDD). Lazard Ltd (LAZ) offers the better valuation at 21. 4x trailing P/E (14. 5x forward), making it the more compelling value choice. Analysts rate JBT Marel Corporation (JBTM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — JBTM or HLI or EVR or MIDD or LAZ?
On trailing P/E, Lazard Ltd (LAZ) is the cheapest at 21.
4x versus Houlihan Lokey, Inc. at 26. 4x. On forward P/E, Lazard Ltd is actually cheaper at 14. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Houlihan Lokey, Inc. wins at 1. 26x versus Evercore Inc. 's 1. 55x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — JBTM or HLI or EVR or MIDD or LAZ?
Over the past 5 years, Houlihan Lokey, Inc.
(HLI) delivered a total return of +141. 5%, compared to -13. 5% for The Middleby Corporation (MIDD). Over 10 years, the gap is even starker: EVR returned +613. 3% versus MIDD's +46. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — JBTM or HLI or EVR or MIDD or LAZ?
By beta (market sensitivity over 5 years), Houlihan Lokey, Inc.
(HLI) is the lower-risk stock at 0. 94β versus Evercore Inc. 's 1. 90β — meaning EVR is approximately 103% more volatile than HLI relative to the S&P 500. On balance sheet safety, Houlihan Lokey, Inc. (HLI) carries a lower debt/equity ratio of 20% versus 3% for Lazard Ltd — giving it more financial flexibility in a downturn.
05Which is growing faster — JBTM or HLI or EVR or MIDD or LAZ?
By revenue growth (latest reported year), JBT Marel Corporation (JBTM) is pulling ahead at 121.
3% versus -17. 4% for The Middleby Corporation (MIDD). On earnings-per-share growth, the picture is similar: Evercore Inc. grew EPS 54. 7% year-over-year, compared to -168. 1% for The Middleby Corporation. Over a 3-year CAGR, JBTM leads at 33. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — JBTM or HLI or EVR or MIDD or LAZ?
Houlihan Lokey, Inc.
(HLI) is the more profitable company, earning 16. 7% net margin versus -8. 7% for The Middleby Corporation — meaning it keeps 16. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HLI leads at 21. 0% versus 5. 0% for JBTM. At the gross margin level — before operating expenses — EVR leads at 99. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is JBTM or HLI or EVR or MIDD or LAZ more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Houlihan Lokey, Inc. (HLI) is the more undervalued stock at a PEG of 1. 26x versus Evercore Inc. 's 1. 55x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Lazard Ltd (LAZ) trades at 14. 5x forward P/E versus 19. 9x for Houlihan Lokey, Inc. — 5. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JBTM: 30. 5% to $180. 00.
08Which pays a better dividend — JBTM or HLI or EVR or MIDD or LAZ?
In this comparison, LAZ (3.
8% yield), HLI (1. 6% yield), EVR (1. 0% yield), JBTM (0. 3% yield) pay a dividend. MIDD does not pay a meaningful dividend and should not be held primarily for income.
09Is JBTM or HLI or EVR or MIDD or LAZ better for a retirement portfolio?
For long-horizon retirement investors, Houlihan Lokey, Inc.
(HLI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 6% yield, +603. 4% 10Y return). Both have compounded well over 10 years (HLI: +603. 4%, JBTM: +156. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between JBTM and HLI and EVR and MIDD and LAZ?
These companies operate in different sectors (JBTM (Industrials) and HLI (Financial Services) and EVR (Financial Services) and MIDD (Industrials) and LAZ (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: JBTM is a small-cap high-growth stock; HLI is a mid-cap high-growth stock; EVR is a mid-cap high-growth stock; MIDD is a small-cap quality compounder stock; LAZ is a small-cap income-oriented stock. HLI, EVR, LAZ pay a dividend while JBTM, MIDD do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.